129453-61-8 Fulvestrant 129453-61-8 seller in China Fulvestrant 129453-61-8 factory in China
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Fulvestrant//CAS No.:129453-61-8
1.Base Date
Name:Fulvestrant
CAS No.:129453-61-8
Molecular formular:C32H47F5O3S
Fulvestrant Chemical structure:
2. Details of Fulvestrant
Superlist Name:Fulvestrant
Molecular Formula:C32H47F5O3S
CAS No.:129453-61-8
Purity:99%
Synonyms:Fulvestrant;(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
Molecular Weight:606.77
3.Description of Fulvestrant
Fulvestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer inpostmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View